Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CASI Pharmaceuticals Inc (NASDAQ:CASI)

1.59
Delayed Data
As of Jul 31
 +0.0199 / +1.27%
Today’s Change
1.07
Today|||52-Week Range
2.13
+19.55%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues1.9M669.3K0.0023.7K
 
 
 
 
Cost of Goods Sold----0.007.5K
 
 
Depreciation And Amortization38.1K20.5K17.4K48.2K
 
 
 
 
 
 
Operating ExpensesGross Income-----17.4K-31.9K
 
 
 
General Expenses6.5M5.2M5.7M6.5M
 
 
 
 
 
Research And Development3.5M2.4M2.7M2.8M
 
 
 
 
 
Total Operating Expenses6.5M5.2M5.7M6.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.6M-4.5M-5.7M-6.5M
 
 
 
 
 
Extraordinary Credit0.000.000.0011.8K
 
 
Extraordinary Charge0.000.000.00-19.7M
 
 
Interest Expense On Debt0.0010.0M0.0028.1K
 
 
 
Other Expenses9.5K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.6M-14.5M-5.7M-26.2M
 
 
 
 
 
Preferred Dividend-1.0M-335.0K0.000.00
 
 
 
Net Income-4.6M-14.5M-5.7M-26.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS11.8M19.1M26.1M28.6M
 
 
 
 
 
Shares To Calculate EPS Diluted11.8M19.1M26.1M28.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.47-$0.78-$0.22-$0.92
 
 
 
 
 
EPS Diluted-$0.47-$0.78-$0.22-$0.92